𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a

✍ Scribed by Ingolf Schiefke; Chris Klecker; Melanie Maier; Ute Oesen; Gunnar Etzrodt; Andrea Tannapfel; Uwe G. Liebert; Frieder Berr

Book ID
111237232
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
134 KB
Volume
24
Category
Article
ISSN
0106-9543

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of lamivudine in patients with
Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB
✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60

Effectiveness of combination therapies w
Effectiveness of combination therapies with 3TC, famciclovir, and alpha interferon against woodchuck hepatitis virus replication in chronically-infected woodchucks: Model for potential anti-HBV treatments: BE Korba1, B Baldwin2, P Cote1, R. Schinazi3, D Gangemi4, JL Gerin1, BC Tennant2, 1- Georgetown Univ., DMVI, Rockville, MD; 2-Coll. Vet. Med., Cornell Univ., Ithaca, NY; 3-Emory Univ., Atlanta, GA; 4-Clemson Univ., Clemson, SC
📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 110 KB
A viral kinetic study using pegylated in
A viral kinetic study using pegylated interferon alpha 2B and lamivudine in naive patients with hepatitis B E antigen negative/hepatitis B virus DNA-positive chronic hepatitis B: Vana Sypsa Mrs, Athens Univ Medical Sch, Athens Greece; Nicolaos C Tassopoulos Mr, Western Attica General Hospital, Athens Greece; Dimitris Chrysagis Mr, Loimodon Hospital, Thessaloniki Greece; Maria Raptopoulou Mrs, Aristoteleion Univ of Thessaloniki, Thessaloniki Greece; Ioannis Ketikoglou Mr, Hippokration General Hospital, Athens Greece; Themistoklis Vassiliadis Mr, Hippokration General Hospital, Thessaloniki Greece; Catherina Haida Mrs, Dimitris Paraskevis Mr, Athens Univ Medical Sch, Athens Greece; Francois Lafleur Mr, Schering Plough, Kenilworth, NJ; Angelos Hatzakis Mr, Athens Univ Medical Sch, Athens Greece
📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB